Glycyrrhizin attenuates the development of carrageenan-induced lung injury in mice

Pharmacological Research

Volumn 58, Issue 1, 2008, Pages 22-31

  Menegazzi, Marta ^a   Di Paola, Rosanna ^b   Mazzon, Emanuela ^b   Genovese, Tiziana ^b   Crisafulli, Concetta ^c   Dal Bosco, Martina ^a   Zou, Zhenzhen ^d   Suzuki, Hisanori ^a   Cuzzocrea, Salvatore ^b,c  

^a UNIVERSITY OF VERONA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d Minophagen Pharmaceutical Co Ltd   (Japan)

Author keywords

Adhesion molecules; Cytokines; Glycyrrhizin; NF B; Nitrotyrosine; PAR; Pleurisy

Indexed keywords

3 NITROTYROSINE; CARRAGEENAN; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; PADGEM PROTEIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); STAT3 PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG POTENCY; GLYCYRRHIZA GLABRA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID PEROXIDATION; LUNG INJURY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLEURISY; PRIORITY JOURNAL; UPREGULATION;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; ENZYME ACTIVATION; GLYCYRRHIZIC ACID; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1BETA; LIPID PEROXIDATION; LUNG; MALE; MICE; NEUTROPHILS; NF-KAPPA B; P-SELECTIN; PEROXYNITROUS ACID; PLEURISY; POLY ADENOSINE DIPHOSPHATE RIBOSE; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 50949123965     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.05.012     Document Type: Article

References (45)

1. Nantel F., Denis D., Gordon R., Northey A., Cirino M., Metters K.M., et al. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Br J Pharmacol 128 (1999) 853-859
2. Xinmin D., Yunyou D., Chaosheng P., Huasong F., Pingkun Z., Jiguang M., et al. Dexamethasone treatment attenuates early seawater instillation-induced acute lung injury in rabbits. Pharmacol Res 53 (2006) 372-379
3. Mariotto S., Esposito E., Di Paola R., Ciampa A., Mazzon E., de Prati A.C., et al. Protective effect of Arbutus unedo aqueous extract in carrageenan-induced lung inflammation in mice. Pharmacol Res 57 (2008) 110-124
4. Schreckand R., and Baeuerle P.A. A role for oxygen radicals as second messengers. Trends Cell Biol 1 (1991) 39-42
5. Schreck R., Rieber P., and Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10 (1991) 2247-2258
6. Brumell J.H., Burkhardt A.L., Bolen J.B., and Grinstein S. Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J Biol Chem 271 (1996) 1455-1461
7. Fialkow L., Wang Y., and Downey G.P. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 42 (2007) 153-164
8. Guoand R.F., and Ward P.A. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal 9 (2007) 1991-2002
9. Mizgerd J.P., Peschon J.J., and Doerschuk C.M. Roles of tumor necrosis factor receptor signaling during murine Escherichia coli pneumonia. Am J Respir Cell Mol Biol 22 (2000) 85-91
10. Mizgerd J.P., Spieker M.R., and Doerschuk C.M. Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J Immunol 166 (2001) 4042-4048
11. Lauzurica P., Martinez-Martinez S., Marazuela M., Gomez del Arco P., Martinez C., Sanchez-Madrid F., et al. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol 29 (1999) 1890-1900
12. Lawrence T., Gilroy D.W., Colville-Nash P.R., and Willoughby D.A. Possible new role for NF-kappaB in the resolution of inflammation. Nat Med 7 (2001) 1291-1297
13. Zhong Z., Wen Z., and Darnell Jr. J.E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264 (1994) 95-98
14. Litvinenkoand V.I., and Obolentseva G.V. Chemical and pharmaceutical research on flavanoids of glycyrrhiza Glabra L. and Glycyrrhiza uralensis Fisch. Med Prom SSSR 18 (1964) 20-23
15. Matsui S., Matsumoto H., Sonoda Y., Ando K., Aizu-Yokota E., Sato T., et al. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line. Int Immunopharmacol 4 (2004) 1633-1644
16. Sato H., Goto W., Yamamura J., Kurokawa M., Kageyama S., Takahara T., et al. Therapeutic basis of glycyrrhizin on chronic hepatitis B. Antiviral Res 30 (1996) 171-177
17. Tamaya T., Sato S., and Okada H.H. Possible mechanism of steroid action of the plant herb extracts glycyrrhizin, glycyrrhetinic acid, and paeoniflorin: inhibition by plant herb extracts of steroid protein binding in the rabbit. Am J Obstet Gynecol 155 (1986) 1134-1139
18. Krahenbuhl S., Hasler F., Frey B.M., Frey F.J., Brenneisen R., and Krapf R. Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans. J Clin Endocrinol Metab 78 (1994) 581-585
19. Takei M., Kobayashi M., Li X.D., Pollard R.B., and Suzuki F. Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine. Pathobiology 72 (2005) 117-123
20. Mullane K.M., Kraemer R., and Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharm Methods 14 (1985) 157-167
21. Schreiber E., Matthias P., Muller M.M., and Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17 (1989) 6419
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
23. van Rossum T.G., Vulto A.G., Hop W.C., Brouwer J.T., Niesters H.G., and Schalm S.W. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J Gastroenterol Hepatol 14 (1999) 1093-1099
24. Su X.S., Chen H.M., Wang L.H., Jiang C.F., Liu J.H., Zhao M.Q., et al. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis. J Tradit Chin Med 4 (1984) 127-132
25. Babaand M., and Shigeta S. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res 7 (1987) 99-107
26. Hattori T., Ikematsu S., Koito A., Matsushita S., Maeda Y., Hada M., et al. Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS. Antiviral Res 11 (1989) 255-261
27. Ito M., Sato A., Hirabayashi K., Tanabe F., Shigeta S., Baba M., et al. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res 10 (1988) 289-298
28. Pompei R., Flore O., Marccialis M.A., Pani A., and Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 281 (1979) 689-690
29. Partridgeand M., and Poswillo D.E. Topical carbenoxolone sodium in the management of herpes simplex infection. Br J Oral Maxillofac Surg 22 (1984) 138-145
30. Numazaki K., Umetsu M., and Chiba S. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection. Tohoku J Exp Med 172 (1994) 147-153
31. Armanini D., Karbowiak I., and Funder J.W. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin Endocrinol 19 (1983) 609-612
32. Okimasu E., Moromizato Y., Watanabe S., Sasaki J., Shiraishi N., Morimoto Y.M., et al. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug. Acta Med Okayama 37 (1983) 385-391
33. Ohuchi K., Kamada Y., Levine L., and Tsurufuji S. Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostaglandins Med 7 (1981) 457-463
34. Akamatsu H., Komura J., Asada Y., and Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med 57 (1991) 119-121
35. Wangand Z.Y., and Nixon D.W. Licorice and cancer. Nutr Cancer 39 (2001) 1-11
36. Haraguchi H., Yoshida N., Ishikawa H., Tamura Y., Mizutani K., and Kinoshita T. Protection of mitochondrial functions against oxidative stresses by isoflavans from Glycyrrhiza glabra. J Pharm Pharmacol 52 (2000) 219-223
37. Nagai T., Egashira T., Yamanaka Y., and Kohno M. The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion. Arch Environ Contam Toxicol 20 (1991) 432-436
38. van Rossum T.G., Vulto A.G., Hop W.C., and Schalm S.W. Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C. Am J Gastroenterol 96 (2001) 2432-2437
39. Eiserich J.P., Cross C.E., Jones A.D., Halliwell B., and van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 271 (1996) 19199-19208
40. Cuzzocrea S., and Wang Z.Q. Role of poly(ADP-ribose) glycohydrolase (PARG) in shock, ischemia and reperfusion. Pharmacol Res 52 (2005) 100-108
41. Ghosh S., May M.J., and Kopp E.B. NF-kappa B. Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16 (1998) 225-260
42. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Patel N.S., Caputi A.P., et al. Tempol reduces the activation of nuclear factor-kappaB in acute inflammation. Free Radic Res 38 (2004) 813-819
43. Yeh C.C., Kao S.J., Lin C.C., Wang S.D., Liu C.J., and Kao S.T. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci 80 (2007) 1821-1831
44. Wyman T.H., Bjornsen A.J., Elzi D.J., Smith C.W., England K.M., Kelher M., et al. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol 283 (2002) C1592-1603
45. Gao H., Guo R.F., Speyer C.L., Reuben J., Neff T.A., Hoesel L.M., et al. Stat3 activation in acute lung injury. J Immunol 172 (2004) 7703-7712